EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cancer molecular subtyping using limited multi-omics data with missingness

Yongqi Bu, Jiaxuan Liang, Zhen Li, Jianbo Wang, Jun Wang, Guoxian Yu iD

PLOS Computational Biology · 2024

DOI: 10.1371/journal.pcbi.1012710 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Computational Biology, 2024. Verfasst von Yongqi Bu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Software, Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Neoplasms, Computational Biology. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Technology Research and Development Program of Shandong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diagnosing cancer subtypes is a prerequisite for precise treatment. Existing multi-omics data fusion-based diagnostic solutions build on the requisite of sufficient samples with complete multi-omics data, which is challenging to obtain in clinical applications. To address the bottleneck of collecting sufficient samples with complete data in clinical applications, we proposed a flexible integrative model (CancerSD) to diagnose cancer subtype using limited samples with incomplete multi-omics data. CancerSD designs contrastive learning tasks and masking-and-reconstruction tasks to reliably impute missing omics, and fuses available omics data with the imputed ones to accurately diagnose cancer subtypes. To address the issue of limited clinical samples, it introduces a category-level contrastive loss to extend the meta-learning framework, effectively transferring knowledge from external datasets to pretrain the diagnostic model. Experiments on benchmark datasets show that CancerSD not only gives accurate diagnosis, but also maintains a high authenticity and good interpretability. In addition, CancerSD identifies important molecular characteristics associated with cancer subtypes, and it defines the Integrated CancerSD Score that can serve as an independent predictive factor for patient prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsComputational BiologyHumansGenomicsAlgorithmsPrognosisBiomarkers, TumorMultiomics

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • School of Software, Shandong University, Jinan, Shandong, China.
  • Joint SDU-NTU Centre for Artificial Intelligence Research, Shandong University, Jinan, Shandong, China.
  • Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • Department of Radiation Oncology, Qilu Hospital of Shandong University, Jinan, Shandong, China.

ORCID-Profile: Guoxian Yu

Förderung

  • Key Technology Research and Development Program of Shandong Province
  • National Natural Science Foundation of China

Zitieren

APA

Bu, Y., Liang, J., Li, Z., Wang, J., Wang, J., & Yu, G. (2024). Cancer molecular subtyping using limited multi-omics data with missingness. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1012710

Vancouver

Bu Y, Liang J, Li Z, Wang J, Wang J, Yu G. Cancer molecular subtyping using limited multi-omics data with missingness. PLOS Computational Biology. 2024. doi:10.1371/journal.pcbi.1012710

BibTeX
@article{Bu2024,
  author = {Bu, Yongqi and Liang, Jiaxuan and Li, Zhen and Wang, Jianbo and Wang, Jun and Yu, Guoxian},
  title = {Cancer molecular subtyping using limited multi-omics data with missingness},
  journal = {PLOS Computational Biology},
  year = {2024},
  doi = {10.1371/journal.pcbi.1012710}
}
Kostenlos starten →